{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,13]],"date-time":"2026-08-13T16:34:09Z","timestamp":1786638849372,"version":"build-2736575974"},"reference-count":36,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,10,12]],"date-time":"2022-10-12T00:00:00Z","timestamp":1665532800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100010269","name":"Wellcome Trust","doi-asserted-by":"publisher","award":["WT102568"],"award-info":[{"award-number":["WT102568"]}],"id":[{"id":"10.13039\/100010269","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000276","name":"Department of Health and Social Care","doi-asserted-by":"publisher","award":["HICF-R8-439"],"award-info":[{"award-number":["HICF-R8-439"]}],"id":[{"id":"10.13039\/501100000276","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["thelancet.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["eClinicalMedicine"],"published-print":{"date-parts":[[2023,1]]},"DOI":"10.1016\/j.eclinm.2022.101716","type":"journal-article","created":{"date-parts":[[2022,11,14]],"date-time":"2022-11-14T17:25:31Z","timestamp":1668446731000},"page":"101716","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":15,"special_numbering":"C","title":["Use of non-selective B-blockers is safe in hospitalised decompensated cirrhosis patients and exerts a potential anti-inflammatory effect: data from the ATTIRE trial"],"prefix":"10.1016","volume":"55","author":[{"given":"Thais","family":"Tittanegro","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Louise","family":"China","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ewan","family":"Forrest","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yiannis","family":"Kallis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen D.","family":"Ryder","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gavin","family":"Wright","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nick","family":"Freemantle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alastair","family":"O'Brien","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.eclinm.2022.101716_bib1","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1056\/NEJM198710013171403","article-title":"Propranolol in the prevention of first upper gastrointestinal tract hemorrhage in patients with cirrhosis of the liver and esophageal varices","volume":"317","author":"Pascal","year":"1987","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.eclinm.2022.101716_bib2","doi-asserted-by":"crossref","first-page":"1431","DOI":"10.1016\/0140-6736(91)93125-S","article-title":"Propranolol in prevention of recurrent bleeding from severe portal hypertensive gastropathy in cirrhosis","volume":"337","author":"Perez-Ayuso","year":"1991","journal-title":"Lancet"},{"key":"10.1016\/j.eclinm.2022.101716_bib3","doi-asserted-by":"crossref","first-page":"1096","DOI":"10.1016\/j.cgh.2016.01.012","article-title":"Nonselective beta-blockers and survival in patients with cirrhosis and ascites: a systematic review and meta-analysis","volume":"14","author":"Chirapongsathorn","year":"2016","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.eclinm.2022.101716_bib4","doi-asserted-by":"crossref","first-page":"1806","DOI":"10.1002\/hep.28575","article-title":"Propranolol use beyond 6 months increases mortality in patients with Child-Pugh C cirrhosis and ascites","volume":"64","author":"Kalambokis","year":"2016","journal-title":"Hepatology"},{"key":"10.1016\/j.eclinm.2022.101716_bib5","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1002\/lt.24744","article-title":"Beneficial and harmful effects of nonselective beta blockade on acute kidney injury in liver transplant candidates","volume":"23","author":"Kim","year":"2017","journal-title":"Liver Transplant"},{"key":"10.1016\/j.eclinm.2022.101716_bib6","doi-asserted-by":"crossref","first-page":"1304","DOI":"10.1111\/liv.13119","article-title":"Effect of propranolol on survival in patients with decompensated cirrhosis: a nationwide study based Danish patient registers","volume":"36","author":"Bang","year":"2016","journal-title":"Liver Int"},{"key":"10.1016\/j.eclinm.2022.101716_bib7","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1002\/hep.23775","article-title":"Deleterious effects of beta-blockers on survival in patients with cirrhosis and refractory ascites","volume":"52","author":"Serste","year":"2010","journal-title":"Hepatology"},{"key":"10.1016\/j.eclinm.2022.101716_bib8","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1136\/gutjnl-2011-301348","article-title":"The window hypothesis: haemodynamic and non-haemodynamic effects of beta-blockers improve survival of patients with cirrhosis during a window in the disease","volume":"61","author":"Krag","year":"2012","journal-title":"Gut"},{"key":"10.1016\/j.eclinm.2022.101716_bib9","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1016\/j.jhep.2021.12.022","article-title":"Baveno VII - renewing consensus in portal hypertension","volume":"76","author":"de Franchis","year":"2022","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.eclinm.2022.101716_bib10","doi-asserted-by":"crossref","first-page":"1597","DOI":"10.1016\/S0140-6736(18)31875-0","article-title":"Beta blockers to prevent decompensation of cirrhosis in patients with clinically significant portal hypertension (PREDESCI): a randomised, double-blind, placebo-controlled, multicentre trial","volume":"393","author":"Villanueva","year":"2019","journal-title":"Lancet"},{"key":"10.1016\/j.eclinm.2022.101716_bib11","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.1111\/j.1478-3231.2009.02038.x","article-title":"beta-Blockers protect against spontaneous bacterial peritonitis in cirrhotic patients: a meta-analysis","volume":"29","author":"Senzolo","year":"2009","journal-title":"Liver Int"},{"key":"10.1016\/j.eclinm.2022.101716_bib12","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1002\/hep.22358","article-title":"Improved survival in patients receiving medical therapy as compared with banding ligation for the prevention of esophageal variceal rebleeding","volume":"48","author":"Lo","year":"2008","journal-title":"Hepatology"},{"key":"10.1016\/j.eclinm.2022.101716_bib13","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1016\/j.jhep.2012.12.011","article-title":"Non-selective betablocker therapy decreases intestinal permeability and serum levels of LBP and IL-6 in patients with cirrhosis","volume":"58","author":"Reiberger","year":"2013","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.eclinm.2022.101716_bib14","doi-asserted-by":"crossref","first-page":"1362","DOI":"10.1016\/j.cgh.2021.07.012","article-title":"Decreasing von Willebrand factor levels upon nonselective beta blocker therapy indicate a decreased risk of further decompensation, acute-on-chronic liver failure, and death","volume":"20","author":"Jachs","year":"2022","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.eclinm.2022.101716_bib15","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1016\/j.jhep.2015.10.018","article-title":"Treatment with non-selective beta blockers is associated with reduced severity of systemic inflammation and improved survival of patients with acute-on-chronic liver failure","volume":"64","author":"Mookerjee","year":"2016","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.eclinm.2022.101716_bib16","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1111\/apt.14366","article-title":"Beta-blockers in hospitalised patients with cirrhosis and ascites: mortality and factors determining discontinuation and reinitiation","volume":"47","author":"Bhutta","year":"2018","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.eclinm.2022.101716_bib17","doi-asserted-by":"crossref","first-page":"1758","DOI":"10.1136\/gutjnl-2020-322712","article-title":"Amelioration of systemic inflammation in advanced chronic liver disease upon beta-blocker therapy translates into improved clinical outcomes","volume":"70","author":"Jachs","year":"2021","journal-title":"Gut"},{"key":"10.1016\/j.eclinm.2022.101716_bib18","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1056\/NEJMoa2022166","article-title":"A\u00a0randomized trial of albumin infusions in hospitalized patients with cirrhosis","volume":"384","author":"China","year":"2021","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.eclinm.2022.101716_bib19","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2015-010902","article-title":"Carvedilol for portal hypertension in cirrhosis: systematic review with meta-analysis","volume":"6","author":"Li","year":"2016","journal-title":"BMJ Open"},{"key":"10.1016\/j.eclinm.2022.101716_bib20","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1016\/j.jhep.2020.06.013","article-title":"The PREDICT study uncovers three clinical courses of acutely decompensated cirrhosis that have distinct pathophysiology","volume":"73","author":"Trebicka","year":"2020","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.eclinm.2022.101716_bib21","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1080\/00273171.2011.568786","article-title":"An introduction to propensity score methods for reducing the effects of confounding in observational studies","volume":"46","author":"Austin","year":"2011","journal-title":"Multivariate Behav Res"},{"key":"10.1016\/j.eclinm.2022.101716_bib22","doi-asserted-by":"crossref","first-page":"1637","DOI":"10.1001\/jama.2015.13480","article-title":"The propensity score","volume":"314","author":"Haukoos","year":"2015","journal-title":"JAMA"},{"key":"10.1016\/j.eclinm.2022.101716_bib23","doi-asserted-by":"crossref","DOI":"10.14309\/ctg.0000000000000476","article-title":"Targeted albumin infusions do not improve systemic inflammation or cardiovascular function in decompensated cirrhosis","volume":"13","author":"China","year":"2022","journal-title":"Clin Transl Gastroenterol"},{"key":"10.1016\/j.eclinm.2022.101716_bib24","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1053\/j.gastro.2019.03.021","article-title":"Effects of albumin treatment on systemic and portal hemodynamics and systemic inflammation in patients with decompensated cirrhosis","volume":"157","author":"Fernandez","year":"2019","journal-title":"Gastroenterology"},{"key":"10.1016\/j.eclinm.2022.101716_bib25","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2018-023754","article-title":"ATTIRE: albumin to prevenT Infection in chronic liveR failurE: study protocol for an interventional randomised controlled trial","volume":"8","author":"China","year":"2018","journal-title":"BMJ Open"},{"key":"10.1016\/j.eclinm.2022.101716_bib26","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1056\/NEJMra0901512","article-title":"Management of varices and variceal hemorrhage in cirrhosis","volume":"362","author":"Garcia-Tsao","year":"2010","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.eclinm.2022.101716_bib27","doi-asserted-by":"crossref","first-page":"746","DOI":"10.1016\/j.jhep.2014.10.028","article-title":"Interaction between infection and hepatic encephalopathy","volume":"62","author":"Merli","year":"2015","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.eclinm.2022.101716_bib28","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1111\/j.1440-1746.2005.03982.x","article-title":"Spontaneous bacterial peritonitis in cirrhotic patients: is prophylactic propranolol therapy beneficial?","volume":"21","author":"Cholongitas","year":"2006","journal-title":"J\u00a0Gastroenterol Hepatol"},{"key":"10.1016\/j.eclinm.2022.101716_bib29","doi-asserted-by":"crossref","first-page":"259","DOI":"10.3109\/10428190009089427","article-title":"Interleukin 8 (IL-8) and the release of leukocytes from the bone marrow","volume":"37","author":"van Eeden","year":"2000","journal-title":"Leuk Lymphoma"},{"key":"10.1016\/j.eclinm.2022.101716_bib30","doi-asserted-by":"crossref","first-page":"6228","DOI":"10.1073\/pnas.092112999","article-title":"Neutrophils are indispensable for hematopoietic stem cell mobilization induced by interleukin-8 in mice","volume":"99","author":"Pruijt","year":"2002","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.eclinm.2022.101716_bib31","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1159\/000342140","article-title":"Dopamine agonists upregulate IL-6 and IL-8 production in human keratinocytes","volume":"19","author":"Parrado","year":"2012","journal-title":"Neuroimmunomodulation"},{"key":"10.1016\/j.eclinm.2022.101716_bib32","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1111\/1440-1681.12261","article-title":"Effects of long-term application of metoprolol and propranolol in a rat model of smoking","volume":"41","author":"Zhou","year":"2014","journal-title":"Clin Exp Pharmacol Physiol"},{"key":"10.1016\/j.eclinm.2022.101716_bib33","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1007\/s00380-008-1048-7","article-title":"Early use of beta-blockers attenuates systemic inflammatory response and lung oxygenation impairment after distal type acute aortic dissection","volume":"23","author":"Jo","year":"2008","journal-title":"Heart Ves"},{"key":"10.1016\/j.eclinm.2022.101716_bib34","first-page":"191","article-title":"Impaired lung oxygenation in acute aortic dissection","volume":"40","author":"Hasegawa","year":"1999","journal-title":"J\u00a0Cardiovasc Surg"},{"key":"10.1016\/j.eclinm.2022.101716_bib35","doi-asserted-by":"crossref","first-page":"48S","DOI":"10.1111\/j.1530-0277.2000.tb00012.x","article-title":"Plasma endotoxin and serum cytokine levels in patients with alcoholic hepatitis: relation to severity of liver disturbance","volume":"24","author":"Fujimoto","year":"2000","journal-title":"Alcohol Clin Exp Res"},{"key":"10.1016\/j.eclinm.2022.101716_bib36","doi-asserted-by":"crossref","DOI":"10.1136\/bmjgast-2019-000290","article-title":"Study protocol for a randomised controlled trial of carvedilol versus variceal band ligation in primary prevention of variceal bleeding in liver cirrhosis (CALIBRE trial)","volume":"6","author":"Tripathi","year":"2019","journal-title":"BMJ Open Gastroenterol"}],"container-title":["eClinicalMedicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2589537022004461?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2589537022004461?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,2,3]],"date-time":"2026-02-03T21:10:02Z","timestamp":1770153002000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2589537022004461"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,1]]},"references-count":36,"alternative-id":["S2589537022004461"],"URL":"https:\/\/doi.org\/10.1016\/j.eclinm.2022.101716","relation":{},"ISSN":["2589-5370"],"issn-type":[{"value":"2589-5370","type":"print"}],"subject":[],"published":{"date-parts":[[2023,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Use of non-selective B-blockers is safe in hospitalised decompensated cirrhosis patients and exerts a potential anti-inflammatory effect: data from the ATTIRE trial","name":"articletitle","label":"Article Title"},{"value":"eClinicalMedicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.eclinm.2022.101716","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 The Author(s). Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"101716"}}